| Financial Year |
March 31 2023 |
| Monetary Funds |
927,679,026.27 |
| Held-for-trading Financial Assets |
77,000,000.00 |
| Notes Receivable |
235,109,479.90 |
| Accounts Receivable |
2,138,693,661.04 |
| Advances to Suppliers |
32,657,975.05 |
| Other Receivables |
-- |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
756,596,700.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
684,542,954.21 |
| Total Current Assets |
5,094,325,085.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,811,745.26 |
| Investment Properties |
141,735,493.36 |
| Fixed Assetes |
296,567,088.87 |
| Under-construction Projects |
1,671,257.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
26,053,083.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,638,718.72 |
| Deferred Income Tax Assets |
68,212,864.04 |
| Other Non-Current Assets |
503,435,034.88 |
| Sub-Total of Non-Current Assets |
1,087,083,824.19 |
| Total Assets |
6,181,408,909.22 |
| Short-Term Loans |
417,083,414.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
446,136,667.87 |
| Accounts Payable |
1,354,805,631.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
76,347,969.78 |
| Taxes Payable |
26,848,098.09 |
| Interest Payable |
-- |
| Dividend Payable |
153,560.00 |
| Other payables |
225,370,573.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
58,487,298.47 |
| Other Current Liabilities |
49,763,056.12 |
| Sub-Total of Current Liabilities |
2,745,358,576.90 |
| Long-term Loans |
122,020,282.36 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-1,940,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,218,633.99 |
| Deferred Income Tax Liabilities |
962,934.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
262,295,833.71 |
| Total Liabilities |
3,007,654,410.61 |
| Paid-In Capital(Or Share Stock) |
1,022,806,646.00 |
| Capital Surplus |
301,839,117.29 |
| Surplus Reserve |
85,630,452.28 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,466,572,100.70 |
| Minority Stockholder's Interest |
275,672,574.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,898,081,924.12 |
| Owner's Equity（Stockholder's Equity） |
3,173,754,498.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,181,408,909.22 |
